<DOC>
	<DOCNO>NCT02977819</DOCNO>
	<brief_summary>As number old people Europe grow , increase healthy life year priority . As people live long , ensure good mental well physical health later year become ever important . Cognitive decline , dementia ( e.g . Alzheimer 's Disease , AD ) , sleep disturbance depression , related psychological distress anxiety , significant driver reduce quality life old adult . This project build evidence meditation practice potential downregulate adverse factor positively impact mental neurological condition include AD .</brief_summary>
	<brief_title>Interventional Study Cognitively Intact Seniors Aiming Assess Effects Meditation Training Foreign Language Learning Behavioral , Biological Neuroimaging Measures</brief_title>
	<detailed_description />
	<criteria>1 . Inclusion Criteria : For participant Age ≥ 65 year ; To autonomous Live home ; Educational level ≥ 7 year ( Preparatory Course ( First grade ) include ) ; To register social security system ; To motivate effectively participate project sign consent form agreement local ethic committee ; Neuropsychological performance within normal range ( accord age , sex , educational level ) , assess diagnostic battery . For participant without previous meditation practice French mother tongue ; Available trial duration ( 24 month ) ; Retired since 1 year ; No preference regard intervention group ; Not regularly intensively practiced meditation comparable practice ( yoga , Qi Gong , Alexander technique ) follow : one day per week six month consecutively last 10 year , intensively ( internship retreat &gt; five consecutive day ) past 10 year , 25 day retreat ( cumulatively ) prior last 10 year ; Not speak English fluently . For expert meditators : Formal meditation practice &gt; 10 000 hour whole life , include least 6 cumulated month retreat ; Daily meditation practice ( least 6 days/week , 45 minutes/day ) ; Mindfulness meditation practice . 2 . Exclusion criterion : Contraindication MRI PET Amyvid® ; For security reason realted use Amyvid® , blood sample allow measure hepatic renal function perform V1 visit PETAmyvid® scan . In case anomaly detect grade 3 high severity , PETAmyvid® scan perform . Hypersensitivity Amyvid® Presence major neurological psychiatric disorder ( include addiction alcohol drug ) ; History cerebral disease ( vascular , degenerative , physical malformation , tumor , head trauma loss consciousness hour ) ; Presence chronic disease acute unstable illness ( respiratory , cardiovascular , digestive , renal , metabolic , hematologic , endocrine infectious ) ; Current recent medication may interfere cognitive action radiological measure ( psychotropic drug , antihistamine , antiParkinsonian drug , benzodiazepine , nonsteroidal antiinflammatory agent , antiepileptic , central analgesic muscle relaxant ) ; Under legal guardianship incapacitation ; Inclusion another biomedical research protocol baseline , include use radiolabel radiological measure ; Physical behavioural inhabilities perform followup visit plan study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>